Wonder Drake Archives
Gut microbiota and lung fibrosis
Feb. 6, 2023—Microorganisms residing in the gut influence the severity of lung fibrosis in mouse models, suggesting that modifying the gut microbiota may offer therapeutic benefit for patients.
Drake, Freedman, Peebles elected AAP members
Apr. 21, 2022—Vanderbilt's Wonder Drake, MD, Jane Freedman, MD, and Stokes Peebles, MD, have been elected to membership in the Association of American Physicians (AAP), one of the nation’s most respected medical honor societies.
HBCU scholars program expanding enrollment
Mar. 11, 2021—The James Puckette Carter Scholars Program, the result of a partnership between Meharry Medical College (MMC), Vanderbilt University Medical Center and the Burroughs Wellcome Fund (BWF), intended to increase the number of physicians who attended Historically Black Colleges and Universities (HBCUs) in health care, is expanding to double its enrollment capacity.
Study reveals new targets to inhibit pulmonary fibrosis
Oct. 4, 2018—In a study out this week in Science Translational Medicine, an international team led by researchers at Vanderbilt University Medical Center sheds new light on the cause of pulmonary fibrosis and demonstrates a way to impede the disease in mice.
Directorships honor VUMC’s critical missions
Jan. 25, 2018—Vanderbilt University Medical Center (VUMC) on Monday held its first Directorship Celebration to honor and support eight of its leaders in clinical care, research, education and administration.
Drake and Terhune named Chancellor’s Higher Education Fellows
Sep. 5, 2017—Dr. Wonder Drake and Dr. Kyla Terhune have been named as the 2017-18 Chancellor’s Higher Education Fellows, Chancellor Nicholas S. Zeppos announced today.
Sarcoidosis research, patient care focus of newly created center
Nov. 17, 2016—Vanderbilt University Medical Center (VUMC) has established a Sarcoidosis Center of Excellence under the direction of Wonder Drake, M.D., associate professor of Medicine and Pathology, Microbiology and Immunology.
Medical societies honor four VUMC physicians
May. 12, 2016—Four physicians from Vanderbilt University Medical Center (VUMC) have been elected to membership in two of the nation’s oldest and most respected medical honor societies — the Association of American Physicians (AAP) and the American Society for Clinical Investigation (ASCI).
A path to sarcoidosis treatment
Sep. 25, 2014—Vanderbilt investigators identify a new therapeutic target for the inflammatory lung disease sarcoidosis.
Sarcoidosis research finds promising oral therapy
Sep. 5, 2013—VUMC researchers have reported promising results in using oral antimycobacterial therapy to treat chronic cutaneous sarcoidosis, considered by clinicians a difficult illness to effectively control.
